This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
We are witnessing a steady and sustainable growth in the country as the Q2 revenue from operations increased by 31%
Net Profit was at Rs. 10.04 crore, as compared to Rs. 5.12 crore in Q2 FY24, clocking a growth of 96.22%
Construction of the plant will commence in 2025 with first production expected to be in 2027
Growth markets revenue increased by 44 YoY to Rs. 812 crore
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
The group plans to establish new hospitals in Kerala developing large health cities in Kochi and Kozhikode
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
Subscribe To Our Newsletter & Stay Updated
